Genetic Analysis AS (XSAT:GEAN)
0.6300
-0.0080 (-1.25%)
At close: May 18, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 44.15 million as of May 19, 2026. Its market cap has decreased by -6.75% in one year.
Market Cap
44.15M
Enterprise Value
28.48M
Revenue
19.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.63
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 44.15M, a decrease of -81.25%. That is a compound annual growth rate of -30.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 44.15M | -0.31% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QBNK Holding AB | 63.38M |
| Sound Dimension AB | 61.01M |
| Beyond Frames Entertainment AB | 58.52M |
| Kontigo Care AB | 52.35M |
| Touchtech AB | 44.56M |
| Redsense Medical AB | 44.07M |
| EcoRub AB | 39.53M |
| MoveByBike Europe AB | 39.27M |